Cost-effective: Low cost capital equipment and consumables. No limitation on aspect ratio: No limitation; Aspect ratio of 10x. Fast prototyping: Commercial.
About
Technology The novel technology developed by the Microfluidic Group in UCD, funded by Enterprise Ireland allows the rapid manufacture of low-cost microfluidic inserts suitable for either small multiple prototype runs or for scale up polymer manufacture of 10,000+ parts using medical polymers, taking less than 1 hour for the manufacture and preparation of industrially viable inserts with features as low as 100 micron. A key issue for production of plastic microfluidics is fabrication of inverted microstructured tools. Mass production tools must be strong, durable, with the required feature size and aspect ratio, maintain a good demolding capability with a feasible draft angle, appropriate surface finish and a good cost/performance ratio. Normally technologies are slow (days) and/or expensive requiring the manufacture . A novel processing technology developed by UCD allows the rapid manufacture of inserts based on any design with features above 100nm.